A healthcare startup needs two sets of numbers: business metrics that show the company is growing, and clinical KPIs that show the product helps patients or clinicians. Start with two to four clinical measures tied to one outcome your buyer cares about, define each precisely, set a baseline, and review them on a fixed schedule. A fractional Chief Medical Officer can help you choose them and defend them to health systems and investors.
TL;DR
- Separate business KPIs (ARR, CAC, churn) from clinical KPIs (outcomes, safety, quality, access). One does not stand in for the other.
- Pick a small set: one outcome measure, a few process measures and at least one balancing (safety) measure.
- Define every KPI with a numerator, denominator, exclusions, data source and baseline before you report it.
- Investors expect outcomes data earlier than many founders plan for, with attrition and baseline severity stated.
- Review the set on a schedule, because a pilot-stage KPI list rarely fits a Series A product.
Table of Contents
- Why clinical KPIs are not ordinary startup metrics
- The three types of clinical KPI: outcome, process and balancing
- Five categories of outcome measure
- How to choose your clinical KPIs
- Define each KPI so it survives scrutiny
- Data sources, baselines and cadence
- Building a pilot scorecard
- Interpreting results and showing progress to investors
- Common mistakes founders make
- Our perspective
- Getting help choosing and defending your KPIs
- FAQ
- Sources
Why clinical KPIs are not ordinary startup metrics
The pages that rank for this topic mostly list generic startup numbers: burn rate, runway, MRR, CAC and churn. You need those. They do not tell a hospital, a health plan or a physician group whether your product works.
In healthcare, retention and revenue can mislead. A MedCity News piece from July 2026 argues that revenue is a misleading KPI in healthcare. It recommends retention-weighted cohort quality over raw acquisition volume. It also recommends keeping business performance metrics such as ARR growth, blended LTV:CAC, payback period and retention by cohort separate from clinical quality metrics such as clinical adherence scoring.
The reasoning is practical. A patient who stays in care for a year is evidence that intake was appropriate, the care model fit the need and the provider relationship held. That is a clinical signal as much as a financial one.
For a SaaS product sold to providers, the same logic applies. Your buyer is not asking how many daily active users you have. They are asking whether outcomes improved, whether staff time dropped and whether any patient was harmed. Engagement still matters, but as a leading indicator of clinical outcomes rather than as the result itself.
We cover the business side in more depth in our guide to healthtech KPIs founders should track by stage and model. Website and marketing numbers belong on a separate dashboard, and a guide to measuring website success with KPIs covers that side. This article stays on the clinical side.
The three types of clinical KPI: outcome, process and balancing
The cleanest way to organize a clinical dashboard comes from the Institute for Healthcare Improvement. Its Model for Improvement guidance recommends a set of roughly 4 to 10 measures, organized into outcome, process and balancing measures, typically with one outcome measure per improvement initiative.
| Type | What it answers | Examples from IHI's guidance |
|---|---|---|
| Outcome | Is the patient or system better off? | Average hemoglobin A1c for a diabetes population; ICU unadjusted mortality |
| Process | Is the work being done the way the model assumes? | Days to the third next available appointment (access) |
| Balancing | Did improving one thing make another worse? | Adverse drug events per 1,000 doses |
For a startup, translate that into your own product:
- Outcome: the change you promise a buyer. For a diabetes platform it might be average A1c in an enrolled cohort. For a behavioral health tool it might be improvement on a validated symptom scale.
- Process: the steps that should lead to the outcome, such as the share of enrolled patients completing a care plan, time to first clinical contact or no-show rate.
- Balancing: what could go wrong as you scale, such as escalations, adverse events linked to the new workflow, patient complaints about the tool or added clinician workload.
Notice what is missing: activation rate and time-in-app. Those belong on the product dashboard. They enter the clinical set only if you can show they predict an outcome.
Five categories of outcome measure
If you are unsure what "outcome" means for your product, the AHRQ registry guide gives a useful taxonomy. AHRQ's Registries for Evaluating Patient Outcomes groups outcomes into five categories: survival, clinical response or status, events of interest, patient-reported outcomes and resource utilization.
That maps well to what startups sell:
- Survival: rarely relevant for early-stage software, except in acute care or monitoring products.
- Clinical response or status: blood pressure control, A1c, symptom scores. The guide notes that these intermediate outcomes make the framework workable for chronic conditions such as asthma or diabetes, where progress is tracked over time.
- Events of interest: complications, treatment-related adverse events or events tied to disease progression. The same guide explains that composite endpoints bundle related outcomes when individual events are rare.
- Patient-reported outcomes: function, symptoms and quality of life as the patient describes them.
- Resource utilization: admissions, emergency visits and other use of care, which is often the number a payer or health system budgets against.
Most seed-stage products can credibly move category 2, 4 or 5 within a pilot. Category 1 and 3 outcomes usually need larger populations and longer follow-up than a pilot allows.
How to choose your clinical KPIs
Start small
Do not build a 30-metric dashboard. The Digital Health Canada Clinical AI Toolkit (May 2026) is a Canadian document, but its approach travels well. It recommends a Minimum Viable Evaluation: start with a small number of indicators, choose 2 to 4 from a library organized across clinical, operational, experience, equity and financial domains, and read early value through time savings, avoided events and workflow impact.
The IHI makes a similar point about discipline. It advises seeking usefulness rather than perfection, using measures that are already being collected and plotting data over time.
Fit the measure to the product, setting and stage
Ask four questions before you commit to a KPI:
- Product: what clinical change does the product plausibly cause, and how soon?
- Care setting: is it ambulatory, inpatient, home or virtual? The data available differ sharply.
- Population: which condition, severity and payer mix? A KPI that works for commercially insured adults may not for Medicaid populations.
- Stage: pre-pilot, pilot, early commercial or scaled? At the pilot stage you want a measure you can move in 60 to 90 days. At scale you need one that holds up across sites.
A 2025 PMC tutorial by McCabe and colleagues on refining and prioritizing KPIs for digital health interventions describes a consensus method. Throughout development, including minimum viable products, it tracks patient empowerment, trust in the platform, usability and accessibility alongside qualitative data from focus groups. The takeaway is that KPI selection is a structured, repeated exercise involving users, not a one-time brainstorm.
Tie the KPI to something your buyer already measures
Clinics and health systems already report against quality programs and contracts. If your KPI maps to a measure on their existing dashboard, your pilot is far easier to approve and your results are easier to read. If it requires them to adopt a new metric, you are adding work to a team that is already stretched.
This is where clinical judgment earns its keep. Someone who has worked inside a care setting knows which numbers a medical director watches and which ones are noise to them. That perspective is the core of what a fractional Chief Medical Officer brings to a startup. We go deeper on this in 2–3 clinical outcomes metrics that guide health systems and SaaS.
Define each KPI so it survives scrutiny
A KPI is only as credible as its definition. The AHRQ-hosted Healthy Hearts Northwest toolkit for clinical quality metric extraction explains that standard clinical quality metrics carry a CMS and National Quality Forum reference number, a type (proportion or continuous variable) and a specificity (patient or episode). Proportion measures need a numerator, a denominator and often exclusions or exceptions.
Write a one-page definition for every KPI:
- Name and purpose: what decision this number informs.
- Numerator: who or what counts as a success.
- Denominator: the eligible population, and how enrollment is timed.
- Exclusions: who is removed and why.
- Data source: EHR report, claims, patient-reported survey or device data.
- Baseline: the pre-intervention period and how it was pulled.
- Cadence and owner: how often it is reviewed and by whom.
If you want to align with national measure language, CMS publishes a guide to how quality measures are developed, used and maintained. It points to the Measures Management System Blueprint and the Measures Inventory Tool. It also lists the typical data sources: claims, electronic clinical data, medical records, surveys, standardized assessments and registries. CMS says quality measures are vetted against five criteria: importance, feasibility, scientific acceptability, usability and use, and harmonization with related measures. Those five are a handy test for your own KPIs.
Data sources, baselines and cadence
The unglamorous part decides whether your numbers are believed.
Data sources. The Healthy Hearts Northwest toolkit notes that practices pull clinical quality data from EHR reports, registries, patient lists or manual chart abstraction. Before you promise a KPI to a buyer, check whether pre-baseline data and aggregate clinic-level data can actually be obtained. Many pilots stall because the baseline cannot be reconstructed.
Validation. The same toolkit recommends four checks:
- Face validity: do the numbers look plausible to a clinician?
- Longitudinal validity: do they behave sensibly over time?
- Benchmarking: how do they compare with national standards?
- Prevalence assessment: does the share of patients flagged match what you would expect?
It adds that a performance rate above 100% usually signals a misread of the exclusion or exception criteria. That is a good rule of thumb for any internal dashboard.
Cadence. Pick a rhythm and keep it. Weekly operational checks, monthly clinical reviews and a quarterly deeper look is a common pattern. The Digital Health Canada toolkit stresses that evaluation is not a one-time exercise: performance, workflow impact and safety signals should be revisited as implementation matures. At a suitable interval, ask whether the intended outcomes were reached at a meaningful threshold, what evidence supports that and what uncertainties remain.
The IHI calls tracking a few key measures over time the single most powerful tool a team can use. A run chart that updates monthly beats a polished report produced once.
Building a pilot scorecard
Here is a worked structure for a startup piloting a workflow tool in an ambulatory clinic. The numbers are illustrative placeholders, not benchmarks.
| Layer | Example KPI | How to define it |
|---|---|---|
| Primary outcome | No-show rate in the enrolled cohort versus baseline | Missed visits divided by scheduled visits, same clinic, same months of the prior year |
| Secondary (process) | Share of patients completing pre-visit forms | Completed forms divided by scheduled visits |
| Secondary (workflow) | Staff time per encounter | Time sampled before and during the pilot |
| Balancing (safety) | Documented adverse events linked to the new workflow | Reviewed by a clinician each month |
| Balancing (experience) | Patient complaints referencing the tool | Count and category, reviewed monthly |
Three design rules keep a scorecard honest. Agree on the definitions with the clinic before the pilot starts. Lock the baseline period. Decide in advance what result counts as success, so nobody moves the goalposts later.
Interpreting results and showing progress to investors
Investors increasingly want outcomes evidence early. A professional guide on mental health startup metrics investors want (October 2026, U.S.) says credible reporting uses validated instruments collected at baseline and fixed intervals. It also uses pre-specified definitions of response, remission, reliable improvement and deterioration, intent-to-treat results with attrition stated, baseline severity, and a comparison such as a published benchmark, matched cohort or controlled study.
The guide sorts what investors look at into five groups: retention, clinical outcomes, unit economics, clinician productivity and safety. At seed, it says companies should show cohort retention and early intent-to-treat outcomes. By Series A they should show repeatable economics, renewals and outcomes that hold up at scale. It is written about mental health, but the structure applies to most digital health categories.
A few practical habits make results more believable:
- Report the denominator. State how many enrolled, how many completed and how many dropped out.
- Show baseline severity. A cohort that started sicker can look worse on a raw average and better on change.
- Be precise about risk adjustment. If your population differs from a benchmark, say so and say how you accounted for it.
- Connect clinical and financial data. Fairview's May 2026 operating-intelligence piece makes the point that linking clinical outcome data to financial data shows whether clinical investment pays back and whether financial pressure is creating quality risk. Whatever tools you use, put a clinical KPI and a financial KPI on the same page.
A board or investor will ask what a number means for a patient. Have the answer ready, in plain language.
Common mistakes founders make
- Treating engagement as the outcome. Daily use that does not change a clinical measure is a product metric, not proof of value.
- Choosing a KPI you cannot baseline. If the pre-period data does not exist, you cannot show change.
- Skipping the balancing measure. Buyers and regulators notice when only good news is tracked.
- Changing definitions mid-pilot. It makes every comparison suspect.
- Reporting only completers. Attrition is part of the result.
- Building the dashboard before the clinical question. Decide what decision each number supports first.
Our perspective
We see the same pattern in healthcare SaaS companies again and again. The product team measures what software can easily count, and the buyer cares about what clinicians and patients experience. The gap between those two lists is where pilots stall and funding conversations get harder.
A fractional Chief Medical Officer is built to close that gap. Our approach is to start from the clinical question: what change does your product cause, in which patients, and how would a physician leader in that setting recognize it? From there the KPI set tends to shrink to a handful of measures you can define, baseline and defend.
Clinical strategy, product evaluation, regulatory guidance and investor support all depend on the same few numbers being right. That is why we pair clinical leadership with an understanding of how startups grow and raise capital, drawing on more than 25 years in medicine and business.
If your dashboard feels misaligned with what your customers ask about, I would welcome a conversation.
Paul Bergeron MD, MBA
Getting help choosing and defending your KPIs
If you are a founder, executive or investor with a portfolio company and want a physician leader to pressure-test your clinical KPIs, that is what we do. The StartUp MD offers Fractional Chief Medical Officer engagements and advisory services for healthcare SaaS startups, covering clinical strategy, product evaluation, market readiness assessment, investor support and executive and board advising. Details are on our services page.
If your product sits in care management, our explainer on care management platforms for healthcare startups shows how these KPIs apply to that category.
FAQ
How many clinical KPIs should a startup track?
Fewer than most founders expect. The IHI recommends roughly 4 to 10 measures in total, split across outcome, process and balancing types, and the Digital Health Canada toolkit suggests starting with 2 to 4 indicators. Add measures only when a specific decision requires them.
What is the difference between a clinical KPI and a SaaS metric?
A SaaS metric such as MRR, CAC or churn describes the health of the business. A clinical KPI describes what happens to patients or care delivery, such as A1c change, symptom score improvement, adverse events or access times. Buyers and investors in healthcare look at both, and neither replaces the other.
What baseline do I need before reporting a clinical KPI?
You need a pre-intervention period for the same population, pulled in the same way as the pilot data. AHRQ-hosted guidance advises checking early whether pre-baseline and aggregate clinic-level data can be obtained. Without that baseline, you can describe results but cannot credibly show change.
Do investors expect clinical outcomes data at seed stage?
Increasingly, yes. A 2026 guide to investor metrics says seed-stage companies should show cohort retention and early intent-to-treat outcomes. By Series A, investors look for repeatable economics, renewals and outcomes that hold up at scale.
Which U.S. frameworks help validate clinical measures?
CMS publishes guidance on how quality measures are developed and maintained, including the Measures Management System Blueprint and Measures Inventory Tool. AHRQ offers toolkits for clinical quality metric extraction and a registry guide for outcome measurement. Use them to borrow definitions, numerators, denominators and validation steps rather than inventing your own.
Sources
- Revenue Is a Misleading KPI in Healthcare, MedCity News
- Model for Improvement: Establishing Measures, Institute for Healthcare Improvement
- Registries for Evaluating Patient Outcomes: A User's Guide, 4th edition, AHRQ
- Clinical AI Toolkit, Digital Health Canada
- How to Refine and Prioritize Key Performance Indicators for Digital Health Interventions, PMC
- Toolkit for Clinical Quality Metric Extraction, AHRQ
- Quality Measures: How They Are Developed, Used, and Maintained, CMS
- Mental Health Startup Metrics: The KPIs Investors Want